Annual Drug Patent Expirations for ZTLIDO
Ztlido is a drug marketed by Scilex Pharms and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
Drug patent litigation for ZTLIDO.
This drug has thirty-two patent family members in eighteen countries.
The generic ingredient in ZTLIDO is lidocaine. One supplier is listed for this compound. Additional details are available on the lidocaine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com